# DEB for Symptomatic Intracranial Atherosclerosis Stenosis

> **NCT04821726** · NA · UNKNOWN · sponsor: **Yinyi(Liaoning) Biotech Co., Ltd.** · enrollment: 155 (actual)

## Conditions studied

- Cerebral Ischemia
- Cerebral Atherosclerosis

## Interventions

- **DEVICE:** Drug eluting balloon (Vmoky)

## Key facts

- **NCT ID:** NCT04821726
- **Lead sponsor:** Yinyi(Liaoning) Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-21
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2023-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04821726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04821726, "DEB for Symptomatic Intracranial Atherosclerosis Stenosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04821726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*